• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ticagrelor and central sleep apnoea: Impact of withdrawal and reintroduction.

作者信息

Puel Vincent, Théophile Hélène, Godard Isabelle, Raymond Nathalie, Miremont-Salamé Ghada, Gosse Philippe, Pépin Jean-Louis, Pariente Antoine

机构信息

PEAS, Nouvelle Clinique Bel-Air, Bordeaux, France.

Département de Pharmacologie Médicale, Centre Régional de Pharmacovigilance, CHU Bordeaux, Bordeaux, France.

出版信息

Br J Clin Pharmacol. 2019 Aug;85(8):1855-1858. doi: 10.1111/bcp.13967. Epub 2019 Jun 17.

DOI:10.1111/bcp.13967
PMID:31206207
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6624382/
Abstract
摘要

相似文献

1
Ticagrelor and central sleep apnoea: Impact of withdrawal and reintroduction.替格瑞洛与中枢性睡眠呼吸暂停：撤药及重新用药的影响
Br J Clin Pharmacol. 2019 Aug;85(8):1855-1858. doi: 10.1111/bcp.13967. Epub 2019 Jun 17.
2
P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects.肾功能不全的急性冠脉综合征患者中的 P2Y12 抑制剂：来自 RENAMI 和 BleeMACS 项目的分析。
Eur Heart J Cardiovasc Pharmacother. 2020 Jan 1;6(1):31-42. doi: 10.1093/ehjcvp/pvz048.
3
Ticagrelor and Central Sleep Apnea.替格瑞洛与中枢性睡眠呼吸暂停
J Am Coll Cardiol. 2018 May 22;71(20):2378-2379. doi: 10.1016/j.jacc.2018.03.447.
4
Prasugrel or Ticagrelor in ST-Segment-Elevation Myocardial Infarction Patients With Diabetes Mellitus.普拉格雷或替卡格雷用于患有糖尿病的ST段抬高型心肌梗死患者
Circulation. 2017 Aug 8;136(6):602-604. doi: 10.1161/CIRCULATIONAHA.117.028745.
5
Frequency, Reasons, and Impact of Premature Ticagrelor Discontinuation in Patients Undergoing Coronary Revascularization in Routine Clinical Practice: Results From the Bern Percutaneous Coronary Intervention Registry.在常规临床实践中接受冠状动脉血运重建的患者中过早停用替格瑞洛的频率、原因和影响：来自伯尔尼经皮冠状动脉介入治疗注册研究的结果。
Circ Cardiovasc Interv. 2018 May;11(5):e006132. doi: 10.1161/CIRCINTERVENTIONS.117.006132.
6
Benefit of Switching Dual Antiplatelet Therapy After Acute Coronary Syndrome According to On-Treatment Platelet Reactivity: The TOPIC-VASP Pre-Specified Analysis of the TOPIC Randomized Study.根据治疗中的血小板反应性评估，急性冠状动脉综合征后转换双联抗血小板治疗的获益：TOPIC-VASP 预先指定分析，TOPIC 随机研究。
JACC Cardiovasc Interv. 2017 Dec 26;10(24):2560-2570. doi: 10.1016/j.jcin.2017.08.044.
7
Effects of Ticagrelor, Prasugrel, or Clopidogrel at Steady State on Endothelial Function.替格瑞洛、普拉格雷或氯吡格雷稳态时对内皮功能的影响。
J Am Coll Cardiol. 2018 Mar 20;71(11):1289-1291. doi: 10.1016/j.jacc.2018.01.027.
8
Pharmacodynamic Effects of Switching From Prasugrel to Ticagrelor: Results of the Prospective, Randomized SWAP-3 Study.从普拉格雷转换为替格瑞洛的药效学效应：前瞻性、随机 SWAP-3 研究的结果。
JACC Cardiovasc Interv. 2016 Jun 13;9(11):1089-98. doi: 10.1016/j.jcin.2016.02.039. Epub 2016 Mar 21.
9
Adenosine and Ticagrelor Plasma Levels in Patients With and Without Ticagrelor-Related Dyspnea.有和没有替格瑞洛相关呼吸困难的患者的腺苷和替格瑞洛血浆水平
Circulation. 2018 Aug 7;138(6):646-648. doi: 10.1161/CIRCULATIONAHA.118.034489.
10
Trends for and Clinical Factors Associated with Choice of Oral P2Y Inhibitors for Patients on Chronic Dialysis.慢性透析患者口服 P2Y 抑制剂选择的趋势及相关临床因素。
Cardiovasc Drugs Ther. 2019 Oct;33(5):511-521. doi: 10.1007/s10557-019-06913-w.

引用本文的文献

1
Central Sleep Apnea in Patients With Coronary Heart Disease Taking P2Y12 Inhibitors.冠心病患者服用 P2Y12 抑制剂后发生中枢性睡眠呼吸暂停。
J Cardiovasc Pharmacol. 2024 Jan 1;83(1):126-130. doi: 10.1097/FJC.0000000000001510.

本文引用的文献

1
Ticagrelor and Central Sleep Apnea.替格瑞洛与中枢性睡眠呼吸暂停
J Am Coll Cardiol. 2018 May 22;71(20):2378-2379. doi: 10.1016/j.jacc.2018.03.447.
2
Dyspnea or Cheyne-Stokes respiration associated with Ticagrelor?替格瑞洛是否会引发呼吸困难或潮式呼吸？
Sleep Med. 2018 Mar;43:4-6. doi: 10.1016/j.sleep.2017.09.033. Epub 2017 Oct 23.
3
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY.2018 年 IUPHAR/BPS 药理学指南：更新和扩展，以包含新的免疫药理学指南。
Nucleic Acids Res. 2018 Jan 4;46(D1):D1091-D1106. doi: 10.1093/nar/gkx1121.
4
Reversal of Ticagrelor-Induced Arrhythmias and Cheyne-Stokes Respiration With Aminophylline Infusion.氨茶碱输注逆转替格瑞洛引起的心律失常和潮式呼吸。
J Cardiovasc Pharmacol. 2017 Nov;70(5):290-292. doi: 10.1097/FJC.0000000000000518.
5
Central Sleep Apnoea Is Related to the Severity and Short-Term Prognosis of Acute Coronary Syndrome.中枢性睡眠呼吸暂停与急性冠状动脉综合征的严重程度及短期预后相关。
PLoS One. 2016 Nov 23;11(11):e0167031. doi: 10.1371/journal.pone.0167031. eCollection 2016.
6
Cheyne-Stokes Respiration, Chemoreflex, and Ticagrelor-Related Dyspnea.陈-施呼吸、化学反射与替格瑞洛相关呼吸困难
N Engl J Med. 2016 Sep 8;375(10):1004-6. doi: 10.1056/NEJMc1601662.
7
Cardiac workload in patients with sleep-disordered breathing early after acute myocardial infarction.急性心肌梗死后睡眠呼吸紊乱患者的心脏负荷。
Chest. 2013 May;143(5):1294-1301. doi: 10.1378/chest.12-1930.
8
Ticagrelor versus clopidogrel in patients with acute coronary syndromes.替格瑞洛与氯吡格雷用于急性冠脉综合征患者的比较
N Engl J Med. 2009 Sep 10;361(11):1045-57. doi: 10.1056/NEJMoa0904327. Epub 2009 Aug 30.
9
Sleep apnea and heart failure: Part II: central sleep apnea.睡眠呼吸暂停与心力衰竭：第二部分：中枢性睡眠呼吸暂停
Circulation. 2003 Apr 8;107(13):1822-6. doi: 10.1161/01.CIR.0000061758.05044.64.